logo

For the Inventor, By the Inventor

Swampscott, MA, United States of America

Richard L Gabriel

This inventor holds 17 USPTO granted patents and 1 published patent application. Top assignees: Pharm-Eco Laboratories, Inc., Interneuron Pharmaceuticals, Inc., Johnson Matthey Pharmaceutical Materials, Inc.. Active years: 1995-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard L Gabriel. Retrieved from https://idiyas.com/inventor/richard-l-gabriel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 

% Patents Active = 94.1

Average Co-Inventor Count = 3.5

ph-index = 5

Forward Citations = 146(Granted Patents)


Company Filing History:

goldMedal14 out of 21 
 
Pharm-Eco Laboratories, Inc.
 patents
silverMedal2 out of 15 
 
Interneuron Pharmaceuticals, Inc.
 patents
bronzeMedal1 out of 2 
 
Johnson Matthey Pharmaceutical Materials, Inc.
 patents

Years Active: 1995-2004

Loading Chart...
17 patents (USPTO):Explore Patents
1. 6677459 - Amino acid derivatives and methods of making the same (2004-01-13),
2. 6590106 - Amino acid derivatives and methods of making the same (2003-07-08),
3. 6479669 - Amino acid derivatives and methods of making the same (2002-11-12),
4. 6462221 - Synthesis of nitroalcohol diastereomers (2002-10-08),
5. 6461858 - Enzyme activated supports for enantiomeric separations (2002-10-08),
6. 6063963 - Amino acid-derived diaminopropanols (2000-05-16),
7. 6020495 - Stereoselective method for synthesizing dolaphenine (2000-02-01),
8. 5750713 - Stereoselective method for synthesizing dolaphenine (1998-05-12),
9. 5643408 - Apparatus for decontaminating a liquid surfactant of dioxane (1997-07-01),
10. 5631405 - Method of forming amino acid-derived diaminopropanols useful as chemical (1997-05-20),
11. 5630914 - Method and apparatus for decontaminating a liquid (1997-05-20),
12. 5618966 - Method forming protease inhibitor synthetic intermediates (1997-04-08),
13. 5599994 - Amino acid-derived diaminopropanols (1997-02-04),
14. 5580878 - Substituted tryptamines phenalkylamines and related compounds (1996-12-03),
15. 5562808 - Method and apparatus for decontaminating a liquid surfactant of dioxane (1996-10-08),

Title: Richard L Gabriel – Innovator in Amino Acid Derivatives

Introduction

Richard L Gabriel, a notable inventor based in Swampscott, Massachusetts, has made significant contributions to the field of pharmaceuticals. With a total of 17 patents to his name, he has established himself as a prominent figure in the innovation landscape, particularly focusing on amino acid derivatives.

Latest Patents

Among his latest patents, Richard L Gabriel has developed innovative methods for creating amino acid derivatives. These advancements not only reflect his commitment to scientific progress but also have implications for various applications within the pharmaceutical industry.

Career Highlights

Over his prolific career, Richard has worked with esteemed companies such as Pharm-Eco Laboratories, Inc. and Interneuron Pharmaceuticals, Inc. His experience in these organizations has allowed him to further refine his expertise and contribute to the development of groundbreaking pharmaceutical products.

Collaborations

Richard has collaborated with distinguished individuals in the field, including Yesh P Sachdeva and Salah A Zahr. These partnerships have enhanced his research capabilities and fostered an environment of innovation that has led to significant breakthroughs in his work.

Conclusion

In conclusion, Richard L Gabriel's influence in the realm of amino acid derivatives showcases his dedication to innovation and his role as a leading inventor. His extensive patent portfolio and collaborations illustrate the profound impact he has had on the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…